Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023

Detalles Bibliográficos
Autores principales: Fleming-Dutra, Katherine E., Ciesla, Allison Avrich, Roper, Lauren E., Smith, Zachary R., Miller, Joseph D., Accorsi, Emma K., Verani, Jennifer R., Shang, Nong, Derado, Gordana, Wiegand, Ryan E., Pilishvili, Tamara, Britton, Amadea, Link-Gelles, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949847/
https://www.ncbi.nlm.nih.gov/pubmed/36795625
http://dx.doi.org/10.15585/mmwr.mm7207a3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949847/
https://www.ncbi.nlm.nih.gov/pubmed/36795625
http://dx.doi.org/10.15585/mmwr.mm7207a3

Ejemplares similares